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Abstract
Background: Next-generation sequencing (NGS) allows for sampling numerous viral variants from infected
patients. This provides a novel opportunity to represent and study the mutational landscape of Hepatitis C Virus
(HCV) within a single host.
Results: Intra-host variants of the HCV E1/E2 region were extensively sampled from 58 chronically infected
patients. After NGS error correction, the average number of reads and variants obtained from each sample were
3202 and 464, respectively. The distance between each pair of variants was calculated and networks were created
for each patient, where each node is a variant and two nodes are connected by a link if the nucleotide distance
between them is 1. The work focused on large components having > 5% of all reads, which in average account
for 93.7% of all reads found in a patient.
The distance between any two variants calculated over the component correlated strongly with nucleotide
distances (r = 0.9499; p = 0.0001), a better correlation than the one obtained with Neighbour-Joining trees (r =
0.7624; p = 0.0001). In each patient, components were well separated, with the average distance between (6.53%)
being 10 times greater than within each component (0.68%). The ratio of nonsynonymous to synonymous changes
was calculated and some patients (6.9%) showed a mixture of networks under strong negative and positive
selection. All components were robust to in silico stochastic sampling; even after randomly removing 85% of all
reads, the largest connected component in the new subsample still involved 82.4% of remaining nodes. In vitro
sampling showed that 93.02% of components present in the original sample were also found in experimental
replicas, with 81.6% of reads found in both. When syringe-sharing transmission events were simulated, 91.2% of all
simulated transmission events seeded all components present in the source.
Conclusions: Most intra-host variants are organized into distinct single-mutation components that are: well
separated from each other, represent genetic distances between viral variants, robust to sampling, reproducible
and likely seeded during transmission events. Facilitated by NGS, large components offer a novel evolutionary
framework for genetic analysis of intra-host viral populations and understanding transmission, immune escape and
drug resistance.
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Background
Hepatitis C virus (HCV) infects nearly 3% of the world’s
population and is a major cause of liver disease worldwide
[1]. There is no vaccine against HCV and up to recently
standard-of-care therapy involved the combined use of
pegylated interferon (peg-IFN) and ribavirin (RBV). This
combination therapy is expensive, effective in only 50%-
60% of patients, and can be associated with frequent and
serious adverse side effects in >75% of patients [2,3].
HCV is genetically very heterogeneous and classified
into 7 genotypes and numerous subgenotypes [4]. HCV
changes continuously during chronic infection, showing a
complex dynamics of intra-host viral subpopulations [5].
The most studied HCV region is the hypervariable region
1 (HVR1) located at amino acid (aa) positions 384-410 in
the structural protein E2. Sequence variation in HVR1 cor-
relates with neutralization escape and is associated with
viral persistence during chronic infection [6-11].
Recent advances in next-generation sequencing (NGS)
methods allow for analysis of the unprecedented number
of HVR1 sequence variants from infected patients and
present a novel opportunity for understanding intra-host
HCV evolution, drug resistance and immune escape [12].
HCV HVR1 variants sampled using NGS from infected
individuals were studied here. We report, for the first
time, that most variants are organized into large single-
mutation connected components. This finding presents a
novel framework for genetic analysis of intra-host HCV
populations, relevant to the study of viral transmission,
immune escape and drug resistance.
Results
One-step networks
Intra-host variants of the E1/E2 region were extensively
sampled from 58 patients chronically infected with HCV
genotypes 1 or 3. After NGS sequencing error correction,
the average number of reads and variants obtained from
each sample were 3202.43 (Standard Error of the Mean,
S.E.M. = 330.41) and 464 (S.E.M. = 79.98), respectively.
In all patients, the average frequency of the major variant
was 0.32 (S.E.M. = 0.03). The distance between each pair
of variants was calculated and networks were created for
each patient, where each node is a variant and two nodes
are connected by a link if the nucleotide distance
between them is 1. The subsequent research was focused
only on large components, which were arbitrarily defined
as encompassing >5% of all reads. This threshold was
chosen because it defines a small number of large com-
ponents that still account for most reads found in a
patient (Mean = 93.7%, S.E.M. = 0.78). In average, a
patient had 2.17 components (S.E.M. = 0.17), ranging
from 1 to 5 in each patient; each component having in
average 172.99 variants (S.E.M. = 20.96) and a total of
1414.85 reads (S.E.M. = 148.23) (Figure 1).
Network topological analysis
All components showed a skewed degree distribution.
Although not strictly following a power-law degree dis-
tribution, most nodes are incident only to one or two
links. The shortest path distances among all pairs of
sequences were estimated, and then the average shortest
path distance for each component was calculated. Over
all components, the average pairwise distance shortest
path was 4.06 (S.E.M. = 0.14), whereas the diameter was
9.24 (S.E.M. = 0.41). Interestingly, the nodes in the com-
ponent did cluster very little (as measured by clustering
coefficient, average over all patients = 0.0071, S.E.M. =
0.002). A low clustering coefficient indicates the absence
of triangles in the network. The only way to form a tri-
angle is to have three sequences that are one mutation
away from each other at the same nucleotide position.
The absence of this network motif simply indicates that
close sequences of this HCV genomic region often differ
at distant positions, instead of differing in states of the
same position.
The component distances highly correlated (average r =
0.9499; S.E.M. = 0.005; all with p = 0.0001) with the Ham-
ming distances between sequences in all patients. When
patristic distances were calculated over a Neighbor-Joining
tree for sequences included in each component, the corre-
lation between the original Hamming distances and tree-
based distances was lower in all cases, with an average of
0.7624 (S.E.M. = 0.01; all with a p = 0.0001). These results
indicate that the distances over the component repre-
sented the true distances more accurately than the dis-
tances over the tree (Figure 2).
In silico sampling robustness
The robustness of each component to sampling bias was
evaluated by measuring the decline in component connec-
tivity with reduction of the sample size. All components
were extraordinarily robust to this type of stochastic sam-
pling; even after randomly removing 85% of all reads, the
largest connected component in the new subsample still
involved 82.42% of the remaining nodes (S.E.M. = 1.69%)
(Figure 3).
In vitro reproducibility
For 16 of the patients, a second sample which was taken
one hour after the first one was available, providing the
opportunity to test whether the components found in
the first sample were also present in the second sample,
an indication of experimental reproducibility. The
results showed that 93.02% of the components present
in the first samples were found in the repeat samples.
For these components found in both samples, we calcu-
lated the fraction of reads found in the first sample that
were also found in the second sample, obtaining an
average over all components of 81.57% (S.E.M. = 18.20)
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Figure 1 One-step components of a single patient. A) Largest one-step component of patient 14, where each node is a variant and two
nodes are connected by a link if the nucleotide distance between them is 1. B) k-step network showing the three components of patient 14.
Each one-step component is shown in a different colour and links among component connect the pairs of variants having the minimal distance
found among components.
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(Figure 4). This result suggests that intra-host subpopu-
lations modelled with components are experimentally
stable. All components missing in the second sample
had an initial frequency between 5.2% and 5.4% of all
reads, indicating that the 5% arbitrary frequency cut-off
chosen in this work for a component to qualify as
“large” is near the limit of experimental replication.
Simulated transmission events
We simulated unsafe injection-related transmission
events using estimates of the number of virions (n = 24)
that may establish productive infection of liver from
contaminated syringes (Methods section). In order to
simulate the transmission event, a random subsample
(recipient) of only 24 reads was taken from the reads of a
given patient (source). For each recipient sample, we
tested the number of components from the source repre-
sented by the sampled reads. Importantly, we found that
91.20% of all simulated transmission events seeded all
components present in the source (S.E.M. = 0.57%), indi-
cating that viral variants that have established infection
in a recipient after transmission likely represent all com-
ponents existing in the source, thus allowing for the
potential reconstitution of these components from a
small but heterogeneous founder population.
Differences among components
The components of each patient were well separated,
with the average Hamming distance between their mem-
bers (average = 6.53%; S.E.M. = 0.18%) being ~10 times
greater than within each component (average = 0.68%;
S.E.M. = 0.04%). For each component, the overall ratio
Figure 2 Scatterplot of hamming distances among the variants of the largest component of patient 14. A) Scatterplot of hamming
distances (x-axis) and shortest path distances over the one-step component (y-axis). B) Scatterplot of hamming distances (x-axis) and shortest
path distances over the Neighbor-Joining tree (y-axis). The R value is the correlation among the two distance matrices. The size of the circles
indicate the number of points (pairwise comparisons) in those coordinates.
Figure 3 In silico sampling robustness of components. Mean over 1000 samples for each component and sampling level, with bars
indicating the 99% confidence interval for the mean. The x-axis represents the percentage of reads removed from the original dataset. The y-
axis represents the percentage of nodes in the subsample that are part of the largest component.
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of nonsynonymous (dN) to synonymous changes (dN)
was calculated. Most of the patients (93.10%) harboured
only negatively selected components, whereas 1.72%
harboured only positively selected components. How-
ever, 3 patients (5.17%) had a mixture of components
under negative or positive selection (Figure 5).
Discussion
RNA viruses exhibit extremely high mutation rates and
given the large population sizes observed in both experi-
mental and natural infections with these viruses, every
possible point mutation and many double-mutation
combinations could theoretically be generated during
each replication cycle within a population. The mutabil-
ity of each viral genome means that RNA virus popula-
tions exist as dynamic mutant networks in which
sequences are continuously diversified and regenerated
by mutation of related sequences, often known as a qua-
sispecies [13]. Connecting viral variants that differ in
one mutation provides a natural framework to organize
the heterogeneous population of viral variants. Although
this has been achieved on theoretical landscapes (e.g.
RNA secondary structures), here we have built these
one-step networks for the first time using viral experi-
mental data, a development just recently enabled by the
NGS technology.
Analyses conducted using in silico and experimental
sampling showed significant robustness of the compo-
nent to stochastic variation, implying that a true compo-
nent will not be split into two due to poor sampling.
Another advantage of the network framework is that
several topological parameters can be calculated (e.g.,
degree distribution, eigenvector centralities, modularity,
motif distribution) for a given patient and then used to
test for differences among different phenotype groupings
(e.g., acute vs. chronic patients, or responders vs. non-
responders of antiviral therapy). Although this topologi-
cal comparison was not performed in the present
research, this network framework provides a new poten-
tial tool for comparing viral populations.
The simulated transmission events may seem too sim-
plified, as selective pressure in the new host environment
will likely be different, affecting intra-host evolution in a
different way. However, the simulation does not deal
with the survival of those seeds, only with their likelihood
of being transmitted. This is in agreement with many
Figure 4 Component overlap. The x-axis represents the 35 components found in the first and second experimental sample. The y-axis shows
the fraction of reads found in the first sample that were also found in the second sample.
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reports on HCV outbreaks, where it is very common that
newly infected cases share variants and are genetically
very close to the transmission source [14]. Based on this,
the purpose of the simulation was to show a very simple
phenomenon: if transmission is purely stochastic (there
are not differences in transmissibility among variants),
then the variants present in the source will be trans-
mitted to the incident case in proportion to their fre-
quency. As was shown in the transmission simulation
experiments, the high frequency of components allows a
small random sample of 20-30 variants to represent with
high probability all of these components in each intra-
host viral population. This important property facilitates
reconstitution of the same component composition of
intra-host viral population from the small number of
founder variants transmitted from one host to another.
The level of genetic separation among large compo-
nents indicates that exploration of all the components
in each infected host likely cannot be accomplished via
a single mutation starting from a single viral variant.
The existence of several subpopulations organized in
one-step components in each infected individual studied
here suggests that the founder viral population was
complex, in agreement with recent findings [15]. The
data obtained in this study indicate that the mechanism
of stochastic sampling is compatible with the complex
founder model and further experiments are underway to
resolve this issue.
HCV changes continuously during chronic infection,
showing a complex dynamics of intra-host viral subpopu-
lations [5]. Large components of HCV variants obtained
from follow-up samples could be used to define viral sub-
populations, whose shifts in frequency over time can be
tracked to pinpoint the sources of drug resistance or
immune escape. The one-step connection provides a sim-
ple biological criterion for identifying the genetic struc-
ture of viral subpopulations. When sampling of intra-
host viral variants is done using NGS, the one-step com-
ponents can be generated for clustering closely related
variants without any assumption on their ancestral origin.
Figure 5 Natural selection of components. The x-axis represents the 58 patients that were analysed. The y-axis represents the number of
components. The blue colour shows the components with dN/dS ratio lower than 1, whereas the red colour indicates the components with
dN/dS ratio higher than 1.
Campo et al. BMC Genomics 2014, 15(Suppl 5):S4
http://www.biomedcentral.com/1471-2164/15/S5/S4
Page 6 of 9
The genetic space occupied by the variants of a given
component will likely be explored very rapidly via single
mutations starting from any variant in each component.
The estimation of the amount of time needed for this
exploration should take into account the kinetic para-
meters of HCV infection (population size, mutation rate,
doubling time, liver volume, etc.). These are currently
being investigated in our laboratory. Given that some
patients harbour a mixture of positively and negatively
selected components, the subpopulations defined by
components may experience different selection pressures,
accounting for the frequency shifts observed during
intra-host evolution in some patients [5].
The distances calculated over the component were
found to be almost identical to the Hamming distances
calculated for all variants, which allows for better visua-
lizing local and global relationships among sequences
and among clusters. It must be noted that other popular
representations of the distance matrix, such as hierarchi-
cal bifurcating trees or Multi-Dimensional Scaling,
reduce dimensionality of data at the cost of accuracy of
distance representation among genetic variants. We have
shown here that patristic distances calculated over the
Neighbor-Joining tree have a significantly lower correla-
tion with the distance matrix than the one-step compo-
nents. A good phylogenetic tree presents a single most
likely history of substitutions, all of which collectively
generated the dataset. However, the key point of our
work is that a single history is an over-simplification
when the whole quasispecies network is continuously
generated over multiple parallel paths. This network set-
ting fits better the highly dynamic process which is the
result of HCV’s large population size, high mutation rate
and fast doubling time.
Although NGS has been instrumental in the acquisition
of a massive number of genomic sequences, the contribu-
tion of these sequences to understanding intra-host viral
evolution have been modest, considering the enormous
amount of genetic information generated by the technol-
ogy [12]. This paradox can, in part, be explained by the
shortage of computational methods for verifying the
accuracy of generated sequences and accommodating
large datasets. However, extensive sequencing of intra-
host viral variants offers also novel opportunities for ana-
lysing genetic information, which are not available for
small samples of sequences. One such approach was
developed in this study. We have shown that one-step
components represent accurately genetic relationships
among the HCV HVR1 variants extensively sampled by
NGS from infected individuals. This likely reflects sam-
pling of numerous intermediates and/or co-existent
ancestors, which allows the parsimonious reconstruction
of the evolutionary process responsible for generation of
the intra-host viral population.
Conclusions
The majority of intra-host HVR1 variants form large
connected components in infected patients. These large
components preserve true distances among variants, are
well separated from each other, are robust to sampling,
and are likely seeded during transmission events. Large
components identified through NGS-facilitated deep
sampling offer a novel evolutionary framework for
genetic analysis of intra-host HCV populations to char-




Intra-host HCV variants were extensively sampled from
58 chronically infected patients with genotypes 1 or 3.
Ethical review and informed consent were granted by
the institutional review boards of Beth Israel Deaconess
Medical Center and the Centers for Disease Control and
Prevention.
Nucleic acid extraction
Total nucleic acids from the specimens were extracted
from serum using the Roche MagNA Pure LC instru-
ment and the MagNA Pure LC Total Nucleic Acid Iso-
lation Kit (Roche Diagnostics, Mannheim, Germany).
RNA was precipitated and reverse-transcribed using
both random and specific primers as previously
described [16]. PCR quantification was conducted by the
COBAS AmpliPrep/COBAS Taq-Man HCV Test (Roche
Diagnostics, Mannheim, Germany), and HCV genotype
determined using the VERSANT HCV Genotype 2.0
Assay (LiPA) (Innogenetics NV, Gent, Belgium).
HVR1 cDNA amplification
The E1/E2 junction of the HCV genome (309 nt), which
contains the HVR1 region, was amplified using our
nested PCR protocol as previously described [16]. The
amplicons generated during first-round PCR were used
as templates for nested PCR using hybrid primers com-
posed of primer adaptors, multiple identifiers and speci-
fic sequences complementary to the HCV genome. This
strategy allowed for multiplexing and downstream pyro-
sequencing. Resulting amplicons were quantified using
the Picogreen kit (Invitrogen, Carlsbad, CA). Integrity of
each fragment was evaluated using Bioanalyzer 2100
(Agilent, Santa Clara, CA).
Next Generation Sequencing (NGS)
PCR products were pooled and subjected to pyrose-
quencing using the GS FLX System and the GS FLX
Titanium Sequencing Kit (454 Life Sciences, Roche,
Branford, CT). Low-quality reads were removed using
the GS Run Processor v2.3 (Roche). Initial reads were
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processed by matching to the corresponding identifier.
The 454 files were processed using the error correction
algorithms KEC and ET [17], which have been validated
to be highly accurate in finding true haplotypes, esti-
mate their frequencies and remove false ones. The
error-corrected files were aligned using Muscle [18] and
the HVR1 sequences clipped to 303 bp.
Nucleotide sequences
The E1/E2 sequences produced in this study can be
found in the following link: http://alan.cs.gsu.edu/
~skumsp/BMC_genomics.fas. The name of the sequence
includes the patient name, a unique identifier, the geno-
type and the absolute frequency (number of reads).
One-step network
The distance between each pair of variants was calcu-
lated and networks were created for each patient, where
each node is a variant and two nodes are connected by
a link if the nucleotide distance between them is 1. The
present work was focused on large components having
more than 5% of all reads. Most analyses in this paper
were performed with MATLAB R2011b (The Math-
Works, Inc., Natick, MA). Network visualization was
achieved with the programs Pajek [19] and Gephi [20].
k-step network
In order to visualize how distant or similar the one-step
components are, a simple method for parsimoniously
connect the components was devised. The k-step net-
work method consist of the following steps: (i) calcula-
tion of the Hamming distance between each pair of
variants belonging to different one-step components; (ii)
determination of the minimum among these distances;
and (iii) establishment of a link among the variants
belonging to different one-step components that have
this minimal distance.
Sampling robustness
For each component, bootstrap samples with replace-
ment were created. Briefly, a number of reads equal to a
defined percentage of the original number of reads was
taken randomly from the original component. The pro-
cedure was repeated at different sampling levels, with
decreasing number of reads in 10% intervals. For each
component and sampling level, the procedure was
repeated 1000 times. For each sample, the one-step net-
work was built and the size of the largest component
was calculated. An average over all samples and a 99%
confidence interval were calculated.
Simulation of transmission events
The average needle-sharing event would transmit 24 vir-
ions, a number based on the following estimates: 2 uL
of blood contaminates a syringE [21]; 1 × 107 virions
per 1000uL of blood [22]; the infection rate is 1.5 × 10-6
per mL/virion/day [23]; and an average liver volume of
1400 mL [24]. In order to simulate the transmission
event, we took all the reads of patient (source) and cre-
ated a subsample with replacement made of 24 reads
(recipient), a process that was repeated 1000 times per
patient. For each recipient sample, we tested how many
components present in the source were represented by
one or more reads.
Evidence of selection
For each component, we calculated the overall ratio of
nonsynonymous substitutions on nonsynonymous sites
(dN) over the synonymous substitutions on synonymous
sites (dS) with a modified version of the single-likeli-
hood ancestor counting (SLAC) algorithm [25]. In our
approach, rather than counting the number of substitu-
tions for each codon over the branches of the phyloge-
netic tree, the number of substitutions was counted over
all the edges of the one-step component.
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